Two Sigma Securities, LLC Mi Nk Therapeutics, Inc. Transaction History
Two Sigma Securities, LLC
- $5.78 Billion
- Q3 2024
A detailed history of Two Sigma Securities, LLC transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 11,937 shares of INKT stock, worth $6,207. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,937Holding current value
$6,207% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INKT
# of Institutions
29Shares Held
848KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA234KShares$121,7740.0% of portfolio
-
Longbow Finance Sa Lutry, V8167KShares$86,6660.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny107KShares$55,4770.0% of portfolio
-
Geode Capital Management, LLC Boston, MA98KShares$50,9500.0% of portfolio
-
Black Rock Inc. New York, NY87.2KShares$45,3410.0% of portfolio
About MiNK Therapeutics, Inc.
- Ticker INKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,775,100
- Market Cap $17.6M
- Description
- MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...